Cited by 289Mesenchymal stem cell researchBone Tissue Engineering MaterialsPeriodontal Regeneration and Treatments

Tissue source determines the differentiation potentials of mesenchymal stem cells: a comparative study of human mesenchymal stem cells from bone marrow and adipose tissue

Open access
Xu, Liangliang, Liu, Yamei, Sun, Yuxin, Wang, Bin, Xiong, Yunpu, Lin, Weiping, Wei, Qiushi, Wang, Haibin +3 more·2017·Stem Cell Research & Therapy

Abstract

BACKGROUND: Mesenchymal stem cells (MSCs) possess intrinsic regeneration capacity as part of the repair process in response to injury, such as fracture or other tissue injury. Bone marrow and adipose tissue are the major sources of MSCs. However, which cell type is more effective and suitable for cell therapy remains to be answered. The intrinsic molecular mechanism supporting the assertion has also been lacking. METHODS: Human bone marrow-derived MSCs (BMSCs) and adipose tissue-derived MSCs (ATSCs) were isolated from bone marrow and adipose tissue obtained after total hip arthroplasty. ATSCs and BMSCs were incubated in standard growth medium. Trilineage differentiation including osteogenesis, adipogenesis, and chondrogenesis was performed by addition of relevant induction mediums. The expression levels of trilineage differentiation marker genes were evaluated by quantitative RT-PCR. The methylation status of CpG sites of Runx2, PPARγ, and Sox9 promoters were checked by bisulfite sequencing. In addition, ectopic bone formation and calvarial bone critical defect models were used to evaluate the bone regeneration ability of ATSCs and BMSCs in vivo. RESULTS: The results showed that BMSCs possessed stronger osteogenic and lower adipogenic differentiation potentials compared to ATSCs. There was no significant difference in the chondrogenic differentiation potential. The CpG sites of Runx2 promoter in BMSCs were hypomethylated, while in ATSCs they were hypermethylated. The CpG sites of PPARγ promoter in ATSCs were hypomethylated, while in BMSCs they were hypermethylated. The methylation status of Sox9 promoter in BMSCs was only slightly lower than that in ATSCs. CONCLUSIONS: The epigenetic memory obtained from either bone marrow or adipose tissue favored MSC differentiation along an osteoblastic or adipocytic lineage. The methylation status of the main transcription factors controlling MSC fate contributes to the differential differentiation capacities of different source-derived MSCs.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13287-017-0716-x

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Studies comparing the osteogenic potential of human BM-MSCs and ASCs have yielded mixed results.

    “Regarding bone tissue engineering, studies comparing the osteogenic potential of human BM-MSCs and ASCs have yielded mixed results.”

    From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [61]

    The Background (page not provided) reports conflicting results from studies comparing ATSCs and BMSCs, but describes those results as concerning clinical application potential, not specifically osteogenic potential. In its own osteogenesis Results, the paper finds greater osteogenic differentiation in BMSCs than ATSCs. The claim therefore narrows the reported disagreement beyond what this source states. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Some studies suggest that BM-MSCs exhibit greater osteogenic capacity than ASCs.

    “Some suggest that BM-MSCs exhibit greater osteogenic capacity [58,59,60,61,62], while others propose that ASCs have equal or superior potential [58,63,64,65,66].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Xu, L., Liu, Y., Sun, Y., Wang, B., Xiong, Y., Lin, W., Wei, Q., Wang, H., He, W., Wang, B., & Li, G.
Affiliations
  • Guangzhou University of Chinese Medicine (CN)
  • Chinese University of Hong Kong (HK)
Corresponding author
  • He, Wei
  • Li, Gang
Venue
Stem Cell Research & Therapy
Published
2017-12
Volume
8
Issue
1
Pages
275-275
ISSN
1757-6512 (ISSN-L)
OpenAlex
W2773440515
Cited by
284
References
36
Citations by year
2026: 10 · 2025: 26 · 2024: 29 · 2023: 50 · 2022: 39 · 2021: 52 · 2020: 34 · 2019: 30 · 2018: 14
FWCI
12.25
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Stem Cell Research & Therapy (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • City University of Hong Kong
  • Lui Che Woo Institute of Innovative Medicine
  • National Natural Science Foundation of China (14119115, 81772322, 81430049, 81371946)
  • Chinese University of Hong Kong
  • Hong Kong Government
Topics
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
  • Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
  • Health Sciences › Medicine › Urology › Periodontal Regeneration and Treatments
Keywords
mesenchymal stem cells, bone marrow-derived stem cells, adipose-derived stem cells, trilineage differentiation, osteogenic differentiation, adipogenesis, chondrogenic differentiation, DNA methylation, Runx2, PPARγ, SOX9, epigenetic memory, bone regeneration, cell therapy
MeSH terms
Adipose Tissue, Bone Marrow Cells, Bone Regeneration, Cell Differentiation, Humans, Organ Specificity, Osteogenesis, Promoter Regions, Genetic, Skull, Biomarkers, Gene Expression, CpG Islands, DNA Methylation, Arthroplasty, Replacement, Hip, Chondrogenesis, Mesenchymal Stem Cell Transplantation, PPAR gamma, Adipogenesis, Core Binding Factor Alpha 1 Subunit, SOX9 Transcription Factor, Mesenchymal Stem Cells, Primary Cell Culture

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review